2023-06-06
¿ÆÑ§¼ÒÕ¹ÏÖhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢
Ê©Íòϸ°û£¨Schwann cells£¬£¬SC£©ÊÇÖÜΧÉñ¾ÏµÍ³ÖÐÖ÷ÒªµÄ½ºÖÊϸ°û¡£¡£SCÓëÐí¶à¼²²¡Óйأ¬£¬ÌÇÄò²¡ÖÜΧÉñ¾²¡±ä£¨Diabetic peripheral neuropathy£¬£¬DPN£©ÊÇÆäÖÐÖ®Ò»¡£¡£ÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽ·ÖУÑо¿Ö°Ô±·¢Ã÷£¬£¬È˶àÐÑĿϸ°û£¨human pluripotent stem cell£¬£¬hPSC£©ÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶Cell Stem Cell¡·ÔÓÖ¾ÉÏ£¬£¬ÌâΪ£ºDeriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy¡£¡£
ÔĶÁ¸ü¶à